Skip to main content
Clinical Trials/IRCT2016022025160N2
IRCT2016022025160N2Completed未知

Comparing the effect of methylphenidate and modafinil in the reduction of methamphetamine withdrawal symptoms and craving

Shiraz University of Medical Sciences0 sites60 target enrollmentStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
未知
Status
Completed
Enrollment
60

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
18 years to 50 years (—)
Sex
Male

Inclusion Criteria

  • Patients' age should be between 18 to 50 years; Patients should fill the informed consent form; Methamphetamine is the main substance of abuse.
  • Exclusion criteria:
  • Patients unwilling to participate at beginning or during the study; Methamphetamine is not the main substance of abuse.

Exclusion Criteria

  • Not provided

Investigators

Similar Trials